Eisai
4523.T
£19.68
Share price
0.84%
Change (1 day)
-37.47%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Market capitalization of Eisai (4523.T)
Market cap: £5.55 Billion
As of April 2025 Eisai has a market cap of £5.55 Billion. This makes Eisai the world's 2048th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Eisai from 2000 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | £5.55 B | -10.42% |
| 2024 | £6.19 B | -44.95% |
| 2023 | £11.25 B | -27.04% |
| 2022 | £15.42 B | 28% |
| 2021 | £12.05 B | -19.8% |
| 2020 | £15.03 B | -8.7% |
| 2019 | £16.46 B | -5.28% |
| 2018 | £17.37 B | 44.44% |
| 2017 | £12.03 B | -10.01% |
| 2016 | £13.36 B | 3.63% |
| 2015 | £12.90 B | 80.04% |
| 2014 | £7.16 B | 6.76% |
| 2013 | £6.71 B | -9.1% |
| 2012 | £7.38 B | -1.79% |
| 2011 | £7.51 B | 12.9% |
| 2010 | £6.66 B | 2.76% |
| 2009 | £6.48 B | -21.53% |
| 2008 | £8.25 B | 40.39% |
| 2007 | £5.88 B | -26.67% |
| 2006 | £8.02 B | 15.38% |
| 2005 | £6.95 B | 41.1% |
| 2004 | £4.92 B | 10.46% |
| 2003 | £4.46 B | 9.21% |
| 2002 | £4.08 B | -19.31% |
| 2001 | £5.06 B | -27.12% |
| 2000 | £6.94 B |
End of Day market cap according to different sources
On Apr 14th, 2025 the market cap of Eisai was reported to be:
£5.50 Billion
£5.50 Billion